Felpreva is the first spot-on parasiticide for cats that covers tapeworms in addition to other endoparasites including gastrointestinal roundworms and lungworms, and ectoparasites (fleas, ticks and mites) for up to three months with a single dose.
It is licensed for treatment of cats with, or at risk from, mixed parasitic infestations/infections, including:
Matthieu Frechin, Vetoquinol CEO, said: “Marketing authorisation is a pivotal achievement for both Vetoquinol and Felpreva.
"It is a breakthrough treatment with convenience and simplicity of use combined with long-lasting efficacy.
"We believe that Felpreva will be a real game changer for this area of veterinary medicine, demonstrating our commitment to the parasiticide market.”
It is anticipated that Felpreva will be available in Europe early in 2022.
PS: Whilst you're here, take a moment to see our latest job opportunities for vets.
Can't remember hearing about it at the 2021 London Vet Show
Publishing Editor: Arlo Guthrie
Clinical Editor: Alasdair Hotston Moore MA VetMB CertSAC CertVR CertSAS FRCVS
Facebook | Linkedin | Instagram | Twitter
Learn more about advertising on VetSurgeon.org
VetSurgeon Jobs is the place to advertise and find permanent and locum jobs for veterinary surgeons in England | Scotland | Wales | Ireland and Worldwide. Follow VS Jobs on Facebook | Linkedin | Twitter
Veterinary Anaesthesia | Veterinary Cardiology | Veterinary Dentistry | Veterinary Dermatology | Diagnostic Imaging | Veterinary ECC | Equine Medicine & Surgery | Farm Animal Medicine & Surgery | Veterinary Medicine | Veterinary Neurology Veterinary Oncology | Veterinary Ophthalmology | Veterinary Orthopaedics | Pathology/Cytology | Veterinary Surgery